Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Fufang Yizhihao is a Traditional Chinese Medicine (specifically a Uyghur medicine) developed and manufactured by Xinjiang Yindolan Weiyao Co., Ltd. It is primarily indicated for the treatment of acute upper respiratory tract infections, common cold, fever, and sore throat. The formulation is a compound of several herbal ingredients, typically including *Achillea wilsoniana* (Yizhihao), *Isatis tinctoria* (Banlangen), and *Artemisia rupestris* (Shiyanzhihao). These components work synergistically to provide antipyretic, anti-inflammatory, and antiviral activities. It is commonly administered in granule form and is a staple of ethnomedicine in the Xinjiang region of China, where it is recognized for its efficacy in managing viral and bacterial respiratory ailments.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Fufang Yizhihao.